CINECA IRIS Institutional Research Information System

ARMANDI, Angelo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.390
AS - Asia 962
EU - Europa 921
SA - Sud America 32
AF - Africa 25
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.339
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.349
IT - Italia 404
SG - Singapore 348
CN - Cina 301
IE - Irlanda 173
SE - Svezia 90
ID - Indonesia 64
DE - Germania 58
VN - Vietnam 46
TW - Taiwan 36
GB - Regno Unito 32
IN - India 31
FR - Francia 29
HK - Hong Kong 28
FI - Finlandia 27
KR - Corea 27
CA - Canada 26
UA - Ucraina 26
JP - Giappone 19
ES - Italia 15
BR - Brasile 13
SA - Arabia Saudita 13
GH - Ghana 11
MX - Messico 11
IL - Israele 10
PK - Pakistan 10
NL - Olanda 9
RU - Federazione Russa 9
AR - Argentina 8
BE - Belgio 8
CL - Cile 8
AU - Australia 7
EG - Egitto 7
TH - Thailandia 7
LU - Lussemburgo 6
AT - Austria 4
CZ - Repubblica Ceca 4
IQ - Iraq 4
IR - Iran 4
JO - Giordania 4
MY - Malesia 4
NG - Nigeria 4
DK - Danimarca 3
GR - Grecia 3
PT - Portogallo 3
RO - Romania 3
TR - Turchia 3
AL - Albania 2
BG - Bulgaria 2
CH - Svizzera 2
CR - Costa Rica 2
EU - Europa 2
NO - Norvegia 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
CI - Costa d'Avorio 1
CO - Colombia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
HU - Ungheria 1
KH - Cambogia 1
LT - Lituania 1
LV - Lettonia 1
MK - Macedonia 1
PA - Panama 1
PH - Filippine 1
PL - Polonia 1
ZA - Sudafrica 1
Totale 4.339
Salva come PNG Salva come JPEG
Città #
Ann Arbor 330
Santa Clara 319
Chandler 312
Singapore 291
Dublin 172
Turin 130
Fairfield 100
Ashburn 98
Columbus 73
Jakarta 61
Beijing 51
Nyköping 51
Hangzhou 43
Princeton 39
Jacksonville 38
Houston 36
Medford 34
Wilmington 34
Milan 33
Seattle 33
Woodbridge 32
Cambridge 29
Torino 29
Dong Ket 28
Tainan City 24
Boston 23
Seoul 23
San Diego 19
Nanjing 18
Helsinki 17
Naples 14
Hong Kong 13
Hebei 12
Munich 12
West Jordan 12
Accra 11
Norwalk 11
Pisa 11
Lappeenranta 10
New York 10
Rome 10
Boardman 9
Chengdu 9
Falls Church 9
Guangzhou 9
London 9
Ottawa 9
Redwood City 9
Toronto 9
Frankfurt am Main 8
Los Angeles 8
Tokyo 8
Wuhan 8
Xi'an 8
Brussels 7
Fremont 7
Shanghai 7
São Paulo 7
Washington 7
Alicante 6
Chennai 6
Dudelange 6
Guiyang 6
Jerusalem 6
Bangkok 5
Dearborn 5
Paris 5
Rochester 5
Santiago 5
Taipei 5
Upper Marlboro 5
Amsterdam 4
Baghdad 4
Bologna 4
Brno 4
Cairo 4
Chicago 4
Islamabad 4
Redmond 4
San Mateo 4
Uboldo 4
Ahmedabad 3
Al Qatif 3
Berlin 3
Birmingham 3
Council Bluffs 3
Dallas 3
Duncan 3
Duruma 3
East Ham 3
Hyderabad 3
Izhevsk 3
Jeddah 3
Karaj 3
Kuala Lumpur 3
Ladispoli 3
Mont-saint-aignan 3
Monterrey 3
Moscow 3
New Delhi 3
Totale 2.955
Salva come PNG Salva come JPEG
Nome #
Dupilumab to target interleukin 4 for inflammatory bowel disease? Hypothesis based on a translational message 184
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: An individual patient data meta-analysis 153
Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report 151
Association Between Gut Permeability and Insulin Resistance: Any Role for Zonulin in Patients with Non-Alcoholic Fatty Liver Disease? 130
Biomarkers of oncogenesis, adipose tissue dysfunction and systemic inflammation for the detection of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease 122
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease 122
On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases 119
The clinical role of serum epidermal growth factor receptor 3 in hepatitis c virus-infected patients with early hepatocellular carcinoma 113
Efficacy of a preparation based on calcium butyrate, bifidobacterium bifidum, bifidobacterium lactis, and fructooligosaccharides in the prevention of relapse in ulcerative colitis: A prospective observational study 112
Can Periodontitis Affect the Health and Disease of the Digestive System? A Comprehensive Review of Epidemiological Evidence and Biological Mechanisms 110
Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology 106
Prevalence of patients with non-alcoholic fatty liver disease: from primary care to tertiary centers. The Turin experience 105
Moving towards core antigen for the management of patients with overt and occult HBV infection 101
Analytical and clinical comparison between two different chemiluminescent enzyme immunoassays for the measurement of C-peptide in serum 98
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease 97
Hepatitis B Core-Related Antigen as Surrogate Biomarker of Intrahepatic Hepatitis B Virus Covalently-Closed-Circular DNA in Patients with Chronic Hepatitis B: A Meta-Analysis 87
Risk Factors of Urothelial Cancer in Inflammatory Bowel Disease 79
Elastography for characterization of focal liver lesions: current evidence and future perspectives 76
Chronic Intestinal Disorders in Humans and Pets: Current Management and the Potential of Nutraceutical Antioxidants as Alternatives 76
Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease 74
Clinical Application of Droplet Digital PCR for Hepatitis Delta Virus Quantification 74
Impact of PNPLA3 rs738409 polymorphism on the development of liver-related events in patients with non-alcoholic fatty liver disease 73
The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review 73
Switching from Biosimilar to Biosimilar Adalimumab, Including Multiple Switching, in Crohn's Disease: A Prospective Study 72
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? 72
Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P 71
Inflammatory Bowel Disease Nurse—Practical Messages 71
A Retrospective Experience of Helicobacter pylori Histology in a Large Sample of Subjects in Northern Italy 70
Increased serum ferritin levels predict long-term mortality in patients with NAFLD 67
Beyond the paradigm of weight loss in non‐alcoholic fatty liver disease: From pathophysiology to novel dietary approaches 64
Derivation and validation of the NAFLD Cirrhosis Score (NCS) to distinguish bridging fibrosis from cirrhosis 60
Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver Disease 57
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Cardiovascular Diseases 56
Non-hepatic Solid Organ Transplant in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series 52
Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver Disease 52
Interplay between metabolic derangement, biomarkers of collagen remodelling and macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease 52
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development 49
Interplay between metabolic derangement, hepatic fibrogenesis and macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease 47
Extracellular vesicles miRNome profiling reveals a close liaison between circulating miRNAs and lipid metabolism derangements in patients with NAFLD 46
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals 45
Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinoma 45
Insulin secretion is an independent predictor of hepatic ballooning in non-diabetic fatty liver disease. 44
Patients with inflammatory bowel disease are at increased risk of atherothrombotic disease: A systematic review with meta-analysis 42
Expression of SARS-Cov-2 Entry Factors in Patients with Chronic Hepatitis 42
Role of triglycerides to high-density lipoprotein cholesterol ratio in non-alcoholic fatty liver disease progression 41
Changes in Liver Stiffness and Markers of Liver Synthesis and Portal Hypertension Following Hepatitis C Virus Eradication in Cirrhotic Individuals 41
Predictive Factors of Surgical Recurrence in Patients with Crohn's Disease on Long-Term Follow-Up: A Focus on Histology 39
Performance of cytokeratin-18 apoptotic fragment for the identification of hepatic fibrosis and inflammation in patients with chronic viral hepatitis: a meta-analysis 39
Epidemiology of Inflammatory Bowel Diseases: A Population Study in a Healthcare District of North-West Italy 37
Prognostic Value of Simple Non-Invasive Tests for the Risk Stratification of Incident Hepatocellular Carcinoma in Cirrhotic Individuals with Non-Alcoholic Fatty Liver Disease 36
Outcomes and potential surrogate markers for future clinical trials of non-alcoholic steatohepatitis cirrhosis 36
Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease 34
Role of Circadian Clock on the Pathogenesis and Lifestyle Management in Non-Alcoholic Fatty Liver Disease 33
Correlation between Polymorphisms of Vitamin D Metabolism Genes and Perianal Disease in Crohn’s Disease 32
Prebiotics targeting gut-liver axis to treat non-alcoholic fatty liver disease 31
Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease 31
Impact of Health Related QoL and Mediterranean Diet on Liver Fibrosis in Patients with NAFLD 27
The Predictive Role of Extracellular NAPRT for the Detection of Advanced Fibrosis in Biopsy-Proven Non-Alcoholic Fatty Liver Disease 25
Prevalence of Multiple Sclerosis in Patients with Inflammatory Bowel Disease 24
Editorial: the polygenic risk of cirrhosis development 24
A nutrigenetic precision approach for the management of non-alcoholic fatty liver disease 22
Natural history of NASH. 21
Accuracy of a dedicated 100 Hz vibration-controlled spleen stiffness measurement for the detection of esophageal varices in naïve patients with compensated advanced chronic liver disease: interim results from a multicentric cohort 20
Emerging concepts in the detection of liver fibrosis in non-alcoholic fatty liver disease 20
Seronegative occult hepatitis C virus infection: what is its clinical relevance? 20
Helicobacter pylori in Inflammatory Bowel Diseases: Active Protagonist or Innocent Bystander? 18
A Healthful Plant-Based Diet as an Alternative Dietary Approach in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease 18
NAFLD between genes and environment: what drives fibrogenesis? 17
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis 17
Echocardiography-based markers of subclinical cardiac dysfunction in individuals with Non-Alcoholic Fatty Liver Disease and preserved ejection fraction: Interim data from a prospective study 16
ACCURACY OF A DEDICATED 100 HZ VIBRATION-CONTROLLED SPLEEN STIFFNESS MEASUREMENT VERSUS BAVENO CRITERIA FOR THE DETECTION OF VARICES IN PATIENTS WITH COMPENSATED CIRRHOSIS 15
Impact of Chronotype and Mediterranean Diet on the Risk of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease 15
Validation of the Blood Test MACK-3 for the Noninvasive Diagnosis of Fibrotic Nonalcoholic Steatohepatitis: An International Study With 1924 Patients 14
Increased prevalence of high-risk coronary plaques in metabolic dysfunction associated stetatotic liver disease patients: A meta-analysis 14
Tight junction regulation in celiac disease: role of larazotide acetate 14
Clinical relevance of serum non-organ-specific antibodies in patients with HCV infection receiving direct-acting antiviral therapy 13
Lifestyle Intervention in NAFLD: Long-Term Diabetes Incidence in Subjects Treated by Web- and Group-Based Programs 10
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease 10
Long-term follow-up of web-based and group-based behavioural intervention in NAFLD in a real world clinical setting 9
Variability of transient elastography-based spleen stiffness performed at 100 Hz 9
Prevalence and risk factors of nonalcoholic steatohepatitis with significant fibrosis in people with HIV 9
NAFLD and NASH: The Metabolically Diseased Liver 9
Impact of thyroid disorders on the incidence of non-alcoholic fatty liver disease in Germany 7
Associations Between Polymorphisms of Genes Related to Vitamin D Pathway and the Response to Vedolizumab and Ustekinumab in Inflammatory Bowel Disease 6
An updated overview on hepatocellular carcinoma in patients with Metabolic dysfunction-Associated Steatotic Liver Disease: Trends, pathophysiology and risk-based surveillance 3
Short‐term reduction of dietary gluten improves metabolic‐dysfunction associated steatotic liver disease: A randomised, controlled proof‐of‐concept study 2
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease 2
Impact of PNPLA3 I148M on Clinical Outcomes in Patients With MASLD 2
Dietary and pharmacological treatment in patients with metabolic-dysfunction associated steatotic liver disease 2
null 1
Totale 4.496
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.852
article - articoli 0
book - libri 0
conference - conferenze 1.230
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.082
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202057 0 0 0 0 0 10 6 2 11 10 8 10
2020/2021469 12 28 15 30 23 30 39 19 65 58 46 104
2021/2022861 21 36 49 37 44 42 152 124 79 45 130 102
2022/2023985 95 69 23 80 105 225 83 50 109 40 48 58
2023/2024844 93 112 47 52 54 79 34 48 17 69 98 141
2024/20251.262 63 197 158 201 464 179 0 0 0 0 0 0
Totale 4.496